Natsume Midori, Baba Seigo
Functional Evaluation Department, Food Science Research Laboratories, R&D Division, Meiji Co., Ltd., 540 Naruda, Odawara, Kanagawa, 250-0862, Japan,
Subcell Biochem. 2014;77:189-98. doi: 10.1007/978-94-007-7920-4_16.
Previous studies in humans have shown that the cacao polyphenols, (-)-epicatechin and its oligomers, prevent in vitro and ex vivo low-density lipoprotein oxidation mediated by free radical generators and metal ions and also reduce plasma LDL-cholesterol levels. The aim of this study was to examine the effects of cacao polyphenols on the development of atherosclerosis in apolipoprotein E-deficient (-/-) mice. Mice aged 8 weeks (n = 90) were randomized into three groups, and fed either normal mouse chow (controls) or chow supplemented with 0.25 or 0.40 % cacao polyphenols for 16 weeks. The mean plaque area in cross-sections of the brachiocephalic trunk was measured and found to be lower in the 0.25 % cacao polyphenol group than in the control group (p < 0.05). Pathological observations showed that accumulation of cholesterol crystals in the plaque area was greater in the control group compared with the 0.40 % cacao polyphenol group (p < 0.05). Immunochemical staining in the 0.25 and 0.40 % groups showed that expression of the cell adhesion molecules (VCAM-1 and ICAM-1) and production of oxidative stress markers (4-hydroxynonenal, hexanoyl-lysine, and dityrosine) were reduced in cross-sections of the brachiocephalic trunk. These results suggest that cacao polyphenols inhibit the development of atherosclerosis in apolipoprotein E-deficient (-/-) mice by reducing oxidative stress and inflammatory responses.
此前针对人类的研究表明,可可多酚、(-)-表儿茶素及其低聚物可在体外和体内防止由自由基生成剂和金属离子介导的低密度脂蛋白氧化,还能降低血浆低密度脂蛋白胆固醇水平。本研究的目的是检验可可多酚对载脂蛋白E缺陷(-/-)小鼠动脉粥样硬化发展的影响。将90只8周龄的小鼠随机分为三组,分别喂食普通小鼠饲料(对照组)或添加0.25%或0.40%可可多酚的饲料,持续16周。测量头臂干横切面的平均斑块面积,发现0.25%可可多酚组的平均斑块面积低于对照组(p<0.05)。病理观察显示,与0.40%可可多酚组相比,对照组斑块区域胆固醇晶体的积累更多(p<0.05)。0.25%和0.40%组的免疫化学染色显示,头臂干横切面中细胞黏附分子(VCAM-1和ICAM-1)的表达以及氧化应激标志物(4-羟基壬烯醛、己酰赖氨酸和二酪氨酸)的产生均减少。这些结果表明,可可多酚通过降低氧化应激和炎症反应,抑制载脂蛋白E缺陷(-/-)小鼠的动脉粥样硬化发展。